Your browser doesn't support javascript.
loading
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
Piccirillo, Maria Carmela; Chu, Quincy; Bradbury, Penelope; Tu, Wei; Coschi, Courtney H; Grosso, Federica; Florescu, Marie; Mencoboni, Manlio; Goffin, John R; Pagano, Maria; Ciardiello, Fortunato; Cecere, Fabiana Letizia; Vincent, Mark; Ferrara, Roberto; Dawe, David E; Hao, Desiree; Lee, Christopher W; Morabito, Alessandro; Gridelli, Cesare; Cavanna, Luigi; Iqbal, Mussawar; Blais, Normand; Leighl, Natasha B; Wheatley-Price, Paul; Tsao, Ming-Sound; Ugo, Francesca; El-Osta, Hazem; Gargiulo, Piera; Gaudreau, Pierre-Olivier; Tu, Dongsheng; Sederias, Joana; Brown-Walker, Pamela; Perrone, Francesco; Seymour, Lesley; Laurie, Scott A.
Afiliação
  • Piccirillo MC; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy.
  • Chu Q; Cross Cancer Institute, Edmonton, Alberta, Canada.
  • Bradbury P; University Health Network, Toronto, Ontario, Canada.
  • Tu W; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Coschi CH; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Grosso F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy.
  • Florescu M; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Mencoboni M; Oncology Unit ASL 3, Villa Scassi Hospital, Genova, Italy.
  • Goffin JR; Juravinski Cancer Centre, Ontario, Canada.
  • Pagano M; Medical Oncology, Comprehensive Cancer Centre, AUSL Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) of Reggio Emilia, Reggio Emilia, Italy.
  • Ciardiello F; Oncology and Hematology Unit, University of Campania "Luigi Vanvitelli," Naples, Italy.
  • Cecere FL; Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituti Fisioterapici Ospitalieri (IFO) Istituto Regina Elena, Rome, Italy.
  • Vincent M; London Regional Cancer Program, London, Ontario, Canada.
  • Ferrara R; Thoracic Oncology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milano, Italy.
  • Dawe DE; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada.
  • Hao D; Tom Baker Cancer Centre and Cumming School of Medicine, Calgary, Alberta, Canada.
  • Lee CW; British Columbia Cancer Agency, Surrey, British Columbia, Canada.
  • Morabito A; Thoracic Oncology Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G. Pascale, Napoli, Italy.
  • Gridelli C; Oncology Unit, S. Giuseppe Moscati Hospital, Avellino, Italy.
  • Cavanna L; Oncology and Hematology Department, USL Piacenza, Guglielmo da Saliceto Hospital, Piacenza, Italy.
  • Iqbal M; Allan Blair Cancer Centre, Regina, Saskatchewan, Canada.
  • Blais N; Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec, Canada.
  • Leighl NB; University Health Network, Toronto, Ontario, Canada.
  • Wheatley-Price P; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Tsao MS; University Health Network, Toronto, Ontario, Canada.
  • Ugo F; Mesothelioma Unit (FG) & Department of Integrated Activities Research and Innovation (FU), SS. Antonio e Biagio C. Arrigo Hospital, Alessandria, Italy.
  • El-Osta H; Merck & Co, Inc., Rahway, New Jersey.
  • Gargiulo P; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy.
  • Gaudreau PO; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Tu D; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Sederias J; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Brown-Walker P; Canadian Cancer Trials Group, Kingston, Ontario, Canada.
  • Perrone F; Clinical Trials Unit, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Fondazione G Pascale, Napoli, Italy.
  • Seymour L; Canadian Cancer Trials Group, Kingston, Ontario, Canada. Electronic address: lseymour@ctg.queensu.ca.
  • Laurie SA; Ottawa Hospital Research Institute and Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
J Thorac Oncol ; 18(6): 813-819, 2023 06.
Article em En | MEDLINE | ID: mdl-36841541
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Mesotelioma Maligno / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pleurais / Mesotelioma Maligno / Neoplasias Pulmonares / Mesotelioma Tipo de estudo: Clinical_trials Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article